A Patient-level Analysis of Efficacy and Hypoglycaemia Outcomes Across Treat-to-target Trials with Insulin Glargine Added to Oral Antidiabetes Agents in People with Type 2 Diabetes [PDF]
J. Hans DeVries +9 more
openalex +1 more source
Once-weekly insulin icodec vs. daily insulin glargine in type 2 diabetes: a meta-analysis with longitudinal insights. [PDF]
Ashraf T +16 more
europepmc +1 more source
Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance [PDF]
David Owens
core +1 more source
Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes [PDF]
Geremia B. Bolli +7 more
openalex +1 more source
Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia. [PDF]
El Sherif IM +3 more
europepmc +1 more source
Role of biosimilar introduction on insulin glargine prices: a retrospective analysis in 28 European countries. [PDF]
Morolla D +4 more
europepmc +1 more source
Timing of Insulin Glargine 300 U/ML: Does It Really Matter in Terms of Efficacy and Safety at Insulin Initiation? [PDF]
Sanyal D, Mitra A.
europepmc +1 more source

